Somewhere in Patna, or Ranchi, or Bhubaneswar, a couple is sitting in silence the evening after receiving a failed IVF cycle result. They have spent somewhere between ₹1.5 lakh and ₹3 lakh. They have taken time off work. The woman has been through injections, retrievals, transfers, a physical and emotional undertaking that is genuinely brutal. And what has the clinic communicated to them in the 48 hours since the result came back negative?
In most cases, nothing is structured. A nurse may have called. A doctor may have said, through an already-crowded OPD, that they can try next cycle again. There is no root-cause review. No counselling touchpoint. No protocol for what comes after the failure, only the quiet, shame-laden assumption that the couple will either pick themselves up and return, or disappear.
Most disappear.
This is not a pastoral care observation. It is a business catastrophe that the Indian fertility sector has collectively chosen not to look at directly.
The Investment Story and the Patient Story Are Not the Same
India’s IVF sector has grown at a pace that attracted serious capital. Clinic chains have expanded footprints. New labs have opened in tier-2 cities. The clinical infrastructure story is genuinely impressive when measured in square footage and cycle volumes.
But measured in patient outcomes and patient trust, a different picture emerges. India performs approximately 300,000 IVF cycles annually against a medically estimated potential of close to one million. That 700,000-cycle gap is not a supply problem. There are enough labs, enough embryologists, and enough stimulation protocols available to treat far more patients than the sector currently does.
The gap is a trust problem. And trust is being destroyed at a very specific, very measurable moment: the post-failed-cycle window.
The Revenue Leak Hiding in Plain Sight
Consider the economics of patient acquisition in Indian IVF. A clinic running a reasonable digital and referral strategy is spending somewhere between ₹40,000 and ₹80,000 to acquire a new patient, factoring in marketing, consultation infrastructure, and the conversion funnel from inquiry to treatment start. This is not a small number. It represents a significant bet on each patient relationship.
Now consider what happens after a failed first cycle. Across the sector, there is no standard protocol. No structured counsellor call within 72 hours. No documented root-cause communication, was it an implementation issue? An embryo quality issue? A protocol question that might be adjusted? Most patients leave the failed cycle conversation without understanding what happened, why it happened, or what would be different the second time.
Into that silence steps shame. In Indian fertility culture, particularly across eastern and central India, infertility already carries a stigma that takes enormous courage to push past. A failed cycle does not reduce that weight. It amplifies it. The couple that scraped together money, told one trusted family member, underwent the procedure quietly, and then failed, they are not going to easily re-enter a clinical environment that never acknowledged their grief.
The clinic has spent ₹40,000–₹80,000 acquiring them. Then, they handed their re-engagement potential and their second-attempt revenue to whoever earns their trust first.
This is the post-failed-cycle void. And it is the single largest recoverable revenue leak in the Indian IVF sector today.
Four Gaps the Sector Has Named but Not Closed
The post-failed-cycle void is the sharpest edge of a broader patient experience problem. But it sits inside a cluster of four systemic failures that, together, explain why demand suppression in Indian IVF is structural rather than incidental.
The information gap. Indian couples typically spend two to three years between first noticing a fertility concern and actually walking into a consultation. That gap is not logistical; clinics exist, and consultations are available. The gap is epistemic. There is no trusted, accessible voice explaining basic fertility biology in Hindi, Bengali, Odia, or Maithili. Couples are navigating through family myth, internet fragments, and the occasional doctor who has thirty seconds between patients. By the time they arrive at a clinic, many have lost years that matter enormously, given the age-related decline in ovarian reserve.
The male factor of silence. In Indian IVF culture, the patient is almost always implicitly the woman. Male factor infertility, which contributes to roughly 40–50% of cases, is examined last, communicated reluctantly, and rarely appears in patient-facing education. The consequence is that couples where the primary factor is male-side are frequently subjected to rounds of female-side investigation and treatment before the actual issue is named. This is both a clinical inefficiency and an empathy failure.
The post-failed-cycle void. As described above, this is the moment where trust is most fragile, and the sector’s response is most absent. No counselling protocol. No root-cause communication standard. No re-engagement pathway. Just silence, and the statistical hope that some percentage of patients will return anyway.
The rural access barrier. Tier-2 cities across eastern India- Ranchi, Patna, Darbhanga, Guwahati, and Bhubaneswar have populations with significant unmet fertility care needs and no mapped, trusted path to treatment. This is not purely a physical access problem. It is a brand trust problem. Couples in these cities know that fertility treatment exists. They do not know who to trust, what the process involves, or whether a clinic in their city or the nearest metro is the right answer. The absence of trusted local infrastructure means needs go unmet, not because treatment is unavailable, but because the first step feels impossible.
Technology Is Not Neutral Either
The patient experience crisis runs parallel to a technology adoption gap that compounds outcomes. AI-assisted embryo selection is standard practice in leading European and American IVF programmes. The evidence base for improved selection accuracy is well-established. Its adoption in Indian tier-2 clinics is close to zero. Telemedicine for fertility monitoring, validated as clinically equivalent to in-person monitoring for specific stages of stimulation protocols, is available but not standard practice. Patient data from cycles is accumulating in physical folders and disconnected EMR systems rather than being analysed to refine protocols over time.
These are not futuristic aspirations. There are available tools that are being systematically underdeployed. The patients who pay for IVF in tier-2 India are receiving a clinical standard that is behind where the science already is.
What the Fix Actually Looks Like
The solution is not more clinics. It is not marketing anymore. It is the structural integration of empathy infrastructure into the clinical model, built as a system, not delivered as individual clinician goodwill.
Specifically, this means a documented counselling protocol that activates within 72 hours of a failed cycle result, not as a sales call, but as a clinical and emotional continuity touchpoint. It means root-cause communication as a standard of care: every failed cycle should produce a structured debrief that the couple can understand in their language. It means male factor evaluation as a first-tier investigation, not an afterthought. It means local-language education at the awareness stage, years before a couple needs a clinic. And it means a telemedicine infrastructure that allows monitoring without the logistical burden of repeated travel, removing a barrier that disproportionately affects tier-2 patients.
This is not what most Indian IVF clinics are building. The capital that has entered the sector has largely built physical infrastructure and brand awareness at the front end of the funnel. The back end, where trust is either earned or destroyed, has been left to individual clinician temperament and chance.
The clinic or platform that systematically closes these gaps in eastern and rural India will not just build a better business. It will move the actual needle on India’s fertility treatment access problem, which is ultimately a public health issue wearing a consumer healthcare mask.
We are building that system. And we will go deeper, in our next piece, on why this is fundamentally an empathy problem masquerading as a logistics problem and what that distinction means for how you design the solution.
Santaan Commitment
At Santaan, we are pioneering the empathy infrastructure essential for India’s IVF sector, delivering structured post-failure counselling, transparent root-cause analysis, localised communication, and AI-optimised care protocols. Fertility innovation demands clinical precision paired with sustained trust. Your path to parenthood merits both.
👉 Contact our Clinical Relations Team
https://www.google.com/search?q=https://santaan.in/contact-us
Technical Metadata